Dopamine (DA) is a neurotransmitter that modulates neural signaling across phylogeny. In humans, disruption of DA signaling is associated with multiple brain disorders including ADHD, schizophrenia, addiction and Parkinson's disease. The DA transporter (DAT) regulates the spatial and temporal dynamics of extracellular DA following vesicular release. Human DAT has been shown to be able to rescue phenotypes associated with a loss of function mutation (lof) in the C. elegans DAT ortholog,
dat-1, supporting a functional conservation of the transporter in regulating DA signaling. Genetic and pharmacological elimination of DAT-1 function results Swimming-induced paralysis (Swip), a phenotype that we have used previously to identify and characterize novel regulators of DA signaling. Here, we present our efforts to characterize one of these mutants,
swip-20. Drugs that suppress DA signaling in humans, reserpine and azaperone, as well as genetic mutations that inhibits DA secretion and signaling were found to restore normal swimming behavior of
swip-20 animals, supporting an impact of
swip-20 mutation on DA signaling. Moreover, overexpression of DAT-1 also restored swimming behavior of
swip-20 animals. Using SNP mapping and whole genome sequencing, the molecular lesion incurred by mutagenesis of
swip-20 was mapped to a locus in chromosome III, as a missense mutation in the catalytic site of a highly-conserved protein bearing a short-chain dehydrogenase/reductase domain. Prior studies across phyla indicate that the
swip-20 gene encodes a protein required for efficient mitochondrial respiration and RNA processing, that in humans has been linked to neurodegenerative disease. In support of our gene identification, energetic and metabolomic analyses revealed
swip-20 mutants to display significantly reduced mitochondrial respiration, elevated oxidized glutathione, and a disrupted redox state, relative to wild-type animals. The in vivo oxidative stress reporter Pgst-4::GFP exhibited elevated expression in
swip-20 mutants. Neurodegeneration and morphological defects were also observed in DA neurons of Swip-20 mutants, suggesting that paralysis derives from poorly controlled DA release and/or hyper-functional postsynaptic DA receptors. Ongoing studies linking disrupted glutamate signaling as a contributor to Swip and neurodegeneration will be presented. Together, our studies establish a new C. elegans model for the study of energetic loss-driven deficits in motor function and neuronal viability.